These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35641993)

  • 21. Long-term efficacy of botulinum toxin type A for the treatment of habitual dislocation of the temporomandibular joint.
    Fu KY; Chen HM; Sun ZP; Zhang ZK; Ma XC
    Br J Oral Maxillofac Surg; 2010 Jun; 48(4):281-4. PubMed ID: 19665263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR-guided navigation for botulinum toxin injection in the lateral pterygoid muscle. First results in the treatment of temporomandibular joint disorders.
    Pons M; Meyer C; Euvrard E; Weber E; Sigaux N; Louvrier A
    J Stomatol Oral Maxillofac Surg; 2019 Jun; 120(3):188-195. PubMed ID: 30453102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IncobotulinumtoxinA Injection for Temporomandibular Joint Disorder.
    Patel AA; Lerner MZ; Blitzer A
    Ann Otol Rhinol Laryngol; 2017 Apr; 126(4):328-333. PubMed ID: 28290229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of temporomandibular disorders with botulinum toxin.
    Schwartz M; Freund B
    Clin J Pain; 2002; 18(6 Suppl):S198-203. PubMed ID: 12569969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum Toxin Type A for Painful Temporomandibular Disorders: Systematic Review and Meta-Analysis.
    Machado D; Martimbianco ALC; Bussadori SK; Pacheco RL; Riera R; Santos EM
    J Pain; 2020; 21(3-4):281-293. PubMed ID: 31513934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K
    Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of multiple injections of botulinum toxin into painful masticatory muscles on bone density in the temporomandibular complex.
    Raphael KG; Janal MN; Tadinada A; Santiago V; Sirois DA; Lurie AG
    J Oral Rehabil; 2020 Nov; 47(11):1319-1329. PubMed ID: 32885475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The human lateral pterygoid muscle.
    Murray GM; Bhutada M; Peck CC; Phanachet I; Sae-Lee D; Whittle T
    Arch Oral Biol; 2007 Apr; 52(4):377-80. PubMed ID: 17141177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent myogenic temporomandibular disorders: Are navigation-guided botulinum toxin-A injections into the lateral pterygoid muscles effective?
    Martenot A; Devoti JF; Pons M; Meyer C; Brumpt E; Louvrier A; Bertin E
    J Stomatol Oral Maxillofac Surg; 2023 Nov; 125(5):101715. PubMed ID: 38013116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporomandibular Disorder Patients Benefit From Intramuscular Botulinum Toxin Type a Injections.
    Oksanen E; Männistö V; Kormi E; Vallioniemi H; Suojanen J
    J Craniofac Surg; 2022 Jun; 33(4):1159-1161. PubMed ID: 34743162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological and positional assessments of TMJ components and lateral pterygoid muscle in relation to symptoms and occlusion of patients with temporomandibular disorders.
    Liu ZJ; Yamagata K; Kuroe K; Suenaga S; Noikura T; Ito G
    J Oral Rehabil; 2000 Oct; 27(10):860-74. PubMed ID: 11065021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promising minimally invasive treatment modalities for symptomatic temporomandibular joint disc displacement with reduction: a randomized controlled clinical trial.
    Rady NA; Bahgat MM; Abdel-Hamid AM
    BMC Oral Health; 2022 Dec; 22(1):547. PubMed ID: 36456937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement in quality of life after botulinum toxin injection for temporomandibular disorder.
    Villa S; Raoul G; Machuron F; Ferri J; Nicot R
    J Stomatol Oral Maxillofac Surg; 2019 Feb; 120(1):2-6. PubMed ID: 30385428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlations between the Helkimo indices and the maximal mandibular excursion capacities of patients with temporomandibular joint disorders.
    Leamari VM; Rodrigues AF; Camino Junior R; Luz JGC
    J Bodyw Mov Ther; 2019 Jan; 23(1):148-152. PubMed ID: 30691742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unclear results for the use of botulinum toxin therapy for TMD pain.
    Keenan JR
    Evid Based Dent; 2015 Dec; 16(4):122. PubMed ID: 26680526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Botulinum Toxin on Masticatory Muscle Pain in Patients with Temporomandibular Disorders: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
    Kim SR; Chang M; Kim AH; Kim ST
    Toxins (Basel); 2023 Oct; 15(10):. PubMed ID: 37888628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum Toxin for Treating Temporomandibular Disorders: What is the Evidence?
    Delcanho R; Val M; Guarda Nardini L; Manfredini D
    J Oral Facial Pain Headache; 2022; 36(1):6-20. PubMed ID: 35298571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of intraarticular botulinum toxin-A injection on symptoms of temporomandibular joint disorder.
    Sari BC; Develi T
    J Stomatol Oral Maxillofac Surg; 2022 Oct; 123(5):e316-e320. PubMed ID: 35523405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Training of the lateral pterygoid muscle in the treatment of temporomandibular joint disc displacement with reduction: A randomised clinical trial.
    Olbort C; Pfanne F; Schwahn C; Bernhardt O
    J Oral Rehabil; 2023 Oct; 50(10):921-930. PubMed ID: 37226632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Botulinum toxin A: analgesic treatment for temporomandibular joint disorders].
    Denglehem C; Maes JM; Raoul G; Ferri J
    Rev Stomatol Chir Maxillofac; 2012 Feb; 113(1):27-31. PubMed ID: 22240328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.